CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Sonia Saxena’s five-year weight loss journey transformed her from an overwhelmed mother at 80 kg to a disciplined, empowered ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...